ExsoMed Announces First 25 INnate™ Intramedullary Threaded Nail Cases for Rapid and Minimally Invasive Treatment of Metacarpal Fractures Successfully Completed in Israel
ExsoMed Corporation, a privately held U.S.-based medical device company providing orthopaedic surgeons with innovative solutions in hand surgery, announced that the first 25 INnate Intramedullary Threaded Nail cases for treatment of metacarpal fractures have been successfully completed in Israel.
ALISO VIEJO, Calif., Sept. 16, 2020 /PRNewswire-PRWeb/ -- ExsoMed Corporation, a privately held U.S.-based medical device company providing orthopaedic surgeons with innovative solutions in hand surgery, announced that the first 25 INnate Intramedullary Threaded Nail cases for treatment of metacarpal fractures have been successfully completed in Israel.
INnate is an intramedullary threaded nail designed specifically for rapid and minimally invasive fixation of metacarpal fractures. The robust length offering with innovative dual crest height design provides optimal fit within the intramedullary canal to create stable fixation and precise reduction. INnate is the only non-compression option, constructed to avoid shortening of oblique and comminuted fractures, while providing simple fracture stabilization in minutes. All instrumentation is sterile-packed and single-use, for stream-lined use in the operating room.
"INnate offers very effective and efficient fixation for metacarpal fractures, saving very valuable OR time," said Dr. Benjamin Kiesh of Herzliya Medical Center in Herzliya, Israel. "My patients are surprised at how soon they can activate their hand immediately after surgery, with hardly any pain."
Based in Tel Aviv, Gad Medical is ExsoMed's exclusive distribution partner for the Israeli market. Founded in 2013 by local medical device executives formerly with Johnson & Johnson orthopaedic subsidiaries DePuy and DePuy Synthes, the organization has grown by more than 50% each year, representing some of the world's most cutting-edge technologies and treatments in healthcare.
"ExsoMed is the latest, exciting addition to Gad Medical's unique portfolio," said Nir Gilat, Gad Medical's senior executive who is responsible for ExsoMed products in Israel. "INnate fits perfectly in our offering, enabling real benefits to patients, surgeons, and the overall Israeli healthcare system, by improving patient outcomes and satisfaction, as well as reducing critical OR time and overall treatment costs."
"Early success and adoption of INnate in Israel further validates our mission to raise the standard of care in hand surgery by providing surgeons with user-friendly surgical tools that reduce the global cost of care and get patients back to work and daily activities faster," said James Young Kim, ExsoMed's Managing Director of Global Sales and Marketing. "As we continue experiencing strong growth in the United States, we are also increasing our international efforts. Gad Medical is just one of our many extraordinary international partners; we are honored that they are a part of the growing ExsoMed family."
About ExsoMed
ExsoMed is a privately held medical device company providing orthopaedic surgeons with innovative solutions in hand surgery. We believe that our solutions raise the standard of care in hand surgery by providing state of the art surgical tools that streamline use in the operating room, reduce the global cost of care, and enhance outcomes so that patients can get back to life faster. For more information regarding ExsoMed, please visit http://www.exsomed.com.
"ExsoMed™ and INnate™ are trademarks of ExsoMed Corporation"
SOURCE ExsoMed Corporation
Share this article